Exiqon’s US business has kicked into gear
Exiqon’s CEO, Lars Kongsbak, is more than pleased with the company’s financial results for Q2 2015 both in terms of operating profit and revenue in a quarter that offered a slight raising of the company’s full-year guidance.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Exiqon CEO: We have created Amazon for life science
For abonnenter
Exiqon buys rights for prostate cancer biomarkers
For abonnenter
Analyst: It looks difficult for Exiqon
For abonnenter